Faculty Collaboration Database

Coronary artery disease prevention: what's different for women? Am Fam Physician 2001 Apr 01;63(7):1393-400, 1405-6

Date

04/20/2001

Pubmed ID

11310652

Scopus ID

2-s2.0-0035310636 (requires institutional sign-in at Scopus site)   37 Citations

Abstract

Cardiovascular disease is the leading cause of death in women, as well as an important cause of disability, although many women and their physicians underestimate the risk. Exercise, hypertension treatment, smoking cessation and aspirin therapy are effective measures for the primary prevention of coronary artery disease in women. The roles of lipid-lowering agents and hormone replacement therapy in primary prevention are not well established. In secondary prevention, hormone replacement therapy has not been effective in lowering the risk of recurrent myocardial infarction, but several lipid-lowering agents have been shown to reduce this risk and to lower mortality rates in women with known coronary artery disease. Other secondary prevention measures, including aspirin, beta blockers, angiotensin-converting enzyme inhibitors, revascularization and rehabilitation, have proven benefits in women but are underused, especially in minority women. Family physicians should emphasize the use of proven treatments, with particular attention given to underserved populations.

Author List

Bedinghaus J, Leshan L, Diehr S

Author

Sabina Diehr MD Professor in the Family Medicine department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Coronary Disease
Female
Hormone Replacement Therapy
Humans
Hyperlipidemias
Hypertension
Male
Prevalence
Primary Prevention
Prognosis
Risk Factors
Sex Factors
Smoking
United States